@article{09a7f8fb0bbe4be28d914ef58c28dbfa,
title = "Association of 5α-Reductase Inhibitor Use with Prostate Cancer-Specific Mortality - Reply",
author = "Lars Bj{\"o}rnebo and Martin Eklund and Anna Lantz",
note = "Funding Information: funding from Pfizer outside the submitted work. Dr R{\o}der reported serving on advisory boards for Astellas Pharma, Pfizer, Janssen-Cilag, Bayer, and MSD outside the submitted work. No other disclosures were reported. Funding Information: Conflict of Interest Disclosures: Dr Eklund reported receiving grants from the Swedish Cancer Society (Cancerfonden; grant CAN21/1512) and Swedish Research Council (Vetenskapr{\aa}det; grant 2018-02526 and the Swedish eScience Research Centre); owning stock in A3P Biomedical AB; and holding patents in A3P Biomedical AB. No other disclosures were reported.",
year = "2022",
month = dec,
day = "15",
doi = "10.1001/jamaoncol.2022.4792",
language = "English",
volume = "8",
pages = "1852--1853",
journal = "JAMA Oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "12",
}